Cargando…

Cost-effectiveness of eplerenone in patients with systolic heart failure and mild symptoms

AIM: In the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF), aldosterone blockade with eplerenone decreased mortality and hospitalisation in patients with mild symptoms (New York Heart Association class II) and chronic systolic heart failure (HF). The pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Dawn, Wilson, Koo, Akehurst, Ron, Cowie, Martin R, Zannad, Faiez, Krum, Henry, van Veldhuisen, Dirk J, Vincent, John, Pitt, Bertram, McMurray, John J V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Heart Failure and Cardiomyopathies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215293/ https://www.ncbi.nlm.nih.gov/pubmed/24993605 http://dx.doi.org/10.1136/heartjnl-2014-305673

Ejemplares similares

Cost-effectiveness of implantable cardiac devices in patients with systolic heart failure
por: Mealing, Stuart, et al.
Publicado: (2016)

Artificial intelligence-assisted interpretation of systolic function by echocardiogram
por: Yamaguchi, Natsumi, et al.
Publicado: (2023)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Five-year outcomes following left ventricular assist device implantation in England
por: Bottle, Alex, et al.
Publicado: (2021)

Changes in heart failure management and long-term mortality over 10 years: observational study
por: Bottle, Alex, et al.
Publicado: (2022)

Real-world presentation with heart failure in primary care: do patients selected to follow diagnostic and management guidelines have better outcomes?
por: Bottle, Alex, et al.
Publicado: (2018)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Verbrugge, Frederik H, et al.
Publicado: (2021)

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices
por: Woods, B, et al.
Publicado: (2015)

Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
por: Scantlebury, Dawn C, et al.
Publicado: (2016)

The systolic paradox in hypertrophic cardiomyopathy
por: Haland, Trine F, et al.
Publicado: (2017)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Exploring the acceptability of implantable defibrillators in patients with cardiac dystrophinopathy and carers
por: Hiermeier, Ursula M, et al.
Publicado: (2020)

Troponin and BNP are markers for subsequent non-ischaemic congestive heart failure: the Caerphilly Prospective Study (CaPS)
por: Patterson, Christopher C, et al.
Publicado: (2018)

Moderate excess alcohol consumption and adverse cardiac remodelling in dilated cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2022)

COMPARATIVE BURDEN OF DELAYED MYOCARDITIS AFTER SARS COV2 AND OTHER ACUTE RESPIRATORY VIRAL INFECTION
por: Begur, Maedha, et al.
Publicado: (2023)

Copper chelation in patients with hypertrophic cardiomyopathy
por: Reid, Anna, et al.
Publicado: (2022)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

OUTCOMES IN THE OUTPATIENT MANAGEMENT OF HEART FAILURE PATIENTS DURING THE COVID-19 PANDEMIC AFTER ROBUST ADOPTION OF A TELEHEALTH MODEL
por: Sammour, Yasser, et al.
Publicado: (2021)

Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team
por: Masters, Jayne, et al.
Publicado: (2017)

Bioactive adrenomedullin, proenkephalin A and clinical outcomes in an acute heart failure setting
por: Molvin, John, et al.
Publicado: (2019)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
por: Massey, Richard John, et al.
Publicado: (2021)

Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017)

Patient characteristics, short-term and long-term outcomes after incident heart failure admissions in a regional Australian setting
por: Al-Omary, Mohammed S, et al.
Publicado: (2022)

Trends in left ventricular assist device use and outcomes among Medicare beneficiaries, 2004–2011
por: Lampropulos, Julianna F, et al.
Publicado: (2014)

Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial
por: Klein, Allan L, et al.
Publicado: (2021)

Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel
por: Spurney, Christopher F, et al.
Publicado: (2021)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Early prediction of left ventricular function improvement in patients with new-onset heart failure and presumed non-ischaemic aetiology
por: Goh, Ze Ming, et al.
Publicado: (2023)

Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification
por: Cubbon, Richard M, et al.
Publicado: (2016)

Daily remote ischaemic conditioning following acute myocardial infarction: a randomised controlled trial
por: Vanezis, Andrew Peter, et al.
Publicado: (2018)

Research priorities in advanced heart failure: James Lind alliance priority setting partnership
por: Taylor, Clare J, et al.
Publicado: (2020)

Direct and indirect effect of the COVID-19 pandemic on patients with cardiomyopathy
por: Hammersley, Daniel J, et al.
Publicado: (2022)

Ferumoxytol-enhanced MRI in patients with prior cardiac transplantation
por: Stirrat, Colin G, et al.
Publicado: (2019)

Ferumoxytol-enhanced magnetic resonance imaging in acute myocarditis
por: Stirrat, Colin G, et al.
Publicado: (2018)

Pathophysiology of exercise intolerance in chronic diseases: the role of diminished cardiac performance in mitochondrial and heart failure patients
por: McCoy, Jodi, et al.
Publicado: (2017)

Association of heart failure and its comorbidities with loss of life expectancy
por: Drozd, Michael, et al.
Publicado: (2021)

Improving the diagnosis of heart failure in patients with atrial fibrillation
por: Bunting, Karina V, et al.
Publicado: (2021)

Rationale and design of a randomised trial of intravenous iron in patients with heart failure
por: Kalra, Paul R, et al.
Publicado: (2022)

Mortality after admission for heart failure in the UK compared with Japan
por: Nagai, Toshiyuki, et al.
Publicado: (2018)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ehi1k3it3flklf3vg9r5o8tskn